AngioDynamics expected to post 11-cent-per-share loss, revenue seen up 6.3%
LSEG mean estimate points to revenue of $80.5 million for the quarter ending Aug. 31, 2026, versus $75.71 million a year ago. Analyst estimate was unchanged over the past three months.
AngioDynamics, Inc. 71 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data. LSEG's mean analyst estimate for AngioDynamics, Inc. is for a loss of 11 cents per share.
" The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for AngioDynamics, Inc. 49 Previous quarterly performance (using preferred earnings measure in US dollars). QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI ENDING ARTESTIMAT ESTIMATE MET, SE % E® MISSED May.
2 Feb. 2 Nov. 00 Beat 100 Aug. 9 May.
03 Beat 75 31 2025 Feb. 1 Nov. 6 Aug. 11 Beat 25 This summary was machine generated September 28 at 12:32 GMT.
All figures in US dollars unless otherwise stated. com. com)